ClinicalTrials.Veeva

Menu

Autologous Stromal Vascular Fraction in the Treatment of Thumb Basal Joint Osteoarthritis (REMEDY SVF)

T

Töölö Hospital

Status

Unknown

Conditions

Thumb Osteoarthritis

Treatments

Other: Splint
Procedure: SVF

Study type

Interventional

Funder types

Other

Identifiers

NCT04455763
1866/2020

Details and patient eligibility

About

Trial purpose is to research the outcome after thumb carpometacarpal injection with stromal vascular fraction (SVF) derived from adipose tissue. The study compares SVF injection therapy with thumb splinting vs. splinting only.

Patients with radiologically and clinically confirmed Eaton-Glickel II osteoarthritis are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo SVF injection and splinting vs. splinting only.

Baseline data is collected preoperatively and patients are followed at 1, 3 and 6 months after enrollment. The primary end-point is 6 months and the primary outcome is pain visual analogue scale and patient-rated wrist evaluation (PRWE).

Enrollment

60 estimated patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 40-70 years
  • Eaton-Glickel II thumb CMC osteoarthrosis
  • Symptom duration > 3 months
  • Pain visual analogue score > 30 mm
  • < 3 months of treatment with thumb splinting
  • American Society of Anaesthesiologists physical status (ASA) I-III
  • Fluent in written and spoken Finnish

Exclusion criteria

  • Age <40 or >70 years
  • Eaton-Glickel I, III-IV
  • Symptom duration < 3 months
  • Pain VAS < 30 mm
  • Post-traumatic osteoarthrosis of thumb CMC I
  • Rheumatoid arthritis or other inflammatory joint disease
  • The use of per oral corticosteroids or other immunomodulatory drugs
  • Less than 6 months after another operation of the same upper limb
  • Other condition of the same upper limb requiring surgery
  • Malnutrition
  • Neurological condition affecting upper limb function
  • Heavy smoking (> 20 cigarettes per day)
  • Alcohol or drug abuse
  • Previous history or active cancer
  • Previous history of allergic reaction to local anaesthetic

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

SVF
Experimental group
Description:
Thumb carpometacarpal injection with adipose-derived SVF combined with splinting
Treatment:
Other: Splint
Procedure: SVF
Splint
Active Comparator group
Description:
Thumb carpometacarpal osteoarthrosis treated with splinting only
Treatment:
Other: Splint

Trial contacts and locations

1

Loading...

Central trial contact

Samuli Aspinen, M.D., Ph.D.; Jussi Kosola, M.D., Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems